395 related articles for article (PubMed ID: 10835629)
1. Identification of the familial cylindromatosis tumour-suppressor gene.
Bignell GR; Warren W; Seal S; Takahashi M; Rapley E; Barfoot R; Green H; Brown C; Biggs PJ; Lakhani SR; Jones C; Hansen J; Blair E; Hofmann B; Siebert R; Turner G; Evans DG; Schrander-Stumpel C; Beemer FA; van Den Ouweland A; Halley D; Delpech B; Cleveland MG; Leigh I; Leisti J; Rasmussen S
Nat Genet; 2000 Jun; 25(2):160-5. PubMed ID: 10835629
[TBL] [Abstract][Full Text] [Related]
2. Multiple familial trichoepithelioma caused by mutations in the cylindromatosis tumor suppressor gene.
Salhi A; Bornholdt D; Oeffner F; Malik S; Heid E; Happle R; Grzeschik KH
Cancer Res; 2004 Aug; 64(15):5113-7. PubMed ID: 15289313
[TBL] [Abstract][Full Text] [Related]
3. Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes.
Ponti G; Nasti S; Losi L; Pastorino L; Pollio A; Benassi L; Giudice S; Bertazzoni G; Veratti E; Azzoni P; Bianchi Scarrà G; Seidenari S
J Cutan Pathol; 2012 Mar; 39(3):366-71. PubMed ID: 22077640
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours.
Leonard N; Chaggar R; Jones C; Takahashi M; Nikitopoulou A; Lakhani SR
J Clin Pathol; 2001 Sep; 54(9):689-92. PubMed ID: 11533075
[TBL] [Abstract][Full Text] [Related]
5. Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12-q13.
Takahashi M; Rapley E; Biggs PJ; Lakhani SR; Cooke D; Hansen J; Blair E; Hofmann B; Siebert R; Turner G; Evans DG; Schrander-Stumpel C; Beemer FA; van Vloten WA; Breuning MH; van den Ouweland A; Halley D; Delpech B; Cleveland M; Leigh I; Chapman P; Burn J; Hohl D; Görög JP; Seal S; Mangion J
Hum Genet; 2000 Jan; 106(1):58-65. PubMed ID: 10982183
[TBL] [Abstract][Full Text] [Related]
6. The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas.
Biggs PJ; Chapman P; Lakhani SR; Burn J; Stratton MR
Oncogene; 1996 Mar; 12(6):1375-7. PubMed ID: 8649842
[TBL] [Abstract][Full Text] [Related]
7. Large germline deletions of the CYLD gene in patients with Brooke-Spiegler syndrome and multiple familial trichoepithelioma.
Vanecek T; Halbhuber Z; Kacerovska D; Martinek P; Sedivcova M; Carr RA; Slouka D; Michal M; Kazakov DV
Am J Dermatopathol; 2014 Nov; 36(11):868-74. PubMed ID: 25347032
[TBL] [Abstract][Full Text] [Related]
8. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens.
Grossmann P; Vanecek T; Steiner P; Kacerovska D; Spagnolo DV; Cribier B; Rose C; Vazmitel M; Carlson JA; Emberger M; Martinek P; Pearce RL; Pearn J; Michal M; Kazakov DV
Am J Dermatopathol; 2013 Feb; 35(1):34-44. PubMed ID: 23249834
[TBL] [Abstract][Full Text] [Related]
9. A clinicopathologic and molecular biologic study of patients presenting with few adnexal tumors (two to four) from the morphological spectrum of Brooke-Spiegler syndrome.
Kacerovska D; Vanecek T; Spagnolo DV; Bisceglia M; Zelger B; Michal M; Kazakov DV
Am J Dermatopathol; 2013 Feb; 35(1):19-24. PubMed ID: 22588548
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells.
Rajan N; Andersson MK; Sinclair N; Fehr A; Hodgson K; Lord CJ; Kazakov DV; Vanecek T; Ashworth A; Stenman G
J Pathol; 2016 Jun; 239(2):197-205. PubMed ID: 26969893
[TBL] [Abstract][Full Text] [Related]
11. A case of Brooke-Spiegler syndrome with a novel mutation in the CYLD gene in a patient with aggressive non-Hodgkin's lymphoma.
Hunstig F; Schulz S; Nieten I; Froster U; Boltze C; Schliemann S; Hochhaus A; La Rosée P
J Cancer Res Clin Oncol; 2016 Apr; 142(4):845-8. PubMed ID: 26660106
[TBL] [Abstract][Full Text] [Related]
12. CYLD mutation causes multiple familial trichoepithelioma in three Chinese families.
Zheng G; Hu L; Huang W; Chen K; Zhang X; Yang S; Sun J; Jiang Y; Luo G; Kong X
Hum Mutat; 2004 Apr; 23(4):400. PubMed ID: 15024746
[TBL] [Abstract][Full Text] [Related]
13. CYLD mutations in familial skin appendage tumours.
Saggar S; Chernoff KA; Lodha S; Horev L; Kohl S; Honjo RS; Brandt HR; Hartmann K; Celebi JT
J Med Genet; 2008 May; 45(5):298-302. PubMed ID: 18234730
[TBL] [Abstract][Full Text] [Related]
14. Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial.
Cranston A; Stocken DD; Stamp E; Roblin D; Hamlin J; Langtry J; Plummer R; Ashworth A; Burn J; Rajan N
Trials; 2017 Mar; 18(1):111. PubMed ID: 28270164
[TBL] [Abstract][Full Text] [Related]
15. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.
Blake PW; Toro JR
Hum Mutat; 2009 Jul; 30(7):1025-36. PubMed ID: 19462465
[TBL] [Abstract][Full Text] [Related]
16. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.
Almeida S; Maillard C; Itin P; Hohl D; Huber M
J Invest Dermatol; 2008 Mar; 128(3):587-93. PubMed ID: 17851586
[TBL] [Abstract][Full Text] [Related]
17. Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene.
Oiso N; Mizuno N; Fukai K; Nakagawa K; Ishii M
Br J Dermatol; 2004 Nov; 151(5):1084-6. PubMed ID: 15541090
[TBL] [Abstract][Full Text] [Related]
18. Phenotype variability in tumor disorders of the skin appendages associated with mutations in the CYLD gene.
Parren LJMT; Giehl K; van Geel M; Frank J
Arch Dermatol Res; 2018 Sep; 310(7):599-606. PubMed ID: 29974194
[TBL] [Abstract][Full Text] [Related]
19. Phenotype-genotype correlations for clinical variants caused by CYLD mutations.
Nagy N; Farkas K; Kemény L; Széll M
Eur J Med Genet; 2015 May; 58(5):271-8. PubMed ID: 25782638
[TBL] [Abstract][Full Text] [Related]
20. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene.
Taylor MD; Gokgoz N; Andrulis IL; Mainprize TG; Drake JM; Rutka JT
Am J Hum Genet; 2000 Apr; 66(4):1403-6. PubMed ID: 10739763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
